- Increases national coverage and scope of services, extending market leadership as the largest, most comprehensive provider of patient-centered intraoperative neuromonitoring
- Grows SCOPE™ database to advance demonstrated expertise in clinical research that is defining industry standards and benchmarks in intraoperative neuromonitoring (IONM)
- Expands the audience that benefits from SpecialtyCare’s transparent quality reporting and ability to help maintain regulatory compliance and avoid penalties
NASHVILLE, TN – October 26, 2016 | SpecialtyCare—a leading provider of outsourced intraoperative neuromonitoring (IONM), perfusion, and surgical services—announced today that it has acquired intraoperative neuromonitoring (IONM) provider Sentient. This transaction extends SpecialtyCare’s market leadership as the largest and most comprehensive provider of patient-centered outsourced IONM services to surgeons, hospitals, surgery centers, and health systems.
With Sentient, SpecialtyCare increases the number of intraoperative neuromonitoring associates available to support cases in existing markets across the United States while adding significant new coverage throughout the Atlantic States. The company now has over 500 IONM professionals supporting 88,000 procedures annually for more than 700 IONM customers and 2,300 surgeons. The acquisition also expands SpecialtyCare’s extensive offering of neuroscience services to include monitoring for Deep Brain Stimulation and interventional neuroradiology, ICU trans-cranial Doppler evaluations, diagnostic EEG, and support of long-term EEG monitoring.
SpecialtyCare CEO, Melvin F. Hall, PhD, said, “I am thrilled to welcome Sentient’s team and customers to SpecialtyCare. This is a great fit for all of us. Both companies place tremendous importance on clinical excellence and customer service, and we share the belief that our associates are our most important asset. Sentient has demonstrated a commitment to ongoing training and advanced certification that mirrors our own industry-leading standards. Together, we will be even better positioned to improve patient outcomes and boost surgeon satisfaction by delivering superior clinical and financial results.”
”We are very excited to join forces with the SpecialtyCare team,” added Brent McCarty, Sentient’s President and CEO. “It became clear during the course of this transaction that SpecialtyCare operates with great integrity, so we know that our staff and our customers are in good hands—and that’s very important to us. Just as SpecialtyCare has a reputation for protecting patients with extensive clinical expertise, the company also shows complete dedication to protecting its customers by maintaining a comprehensive compliance program and adhering to regulatory standards. That says a lot about who SpecialtyCare is, and it will be well-received by our customers who understand the severe penalties of healthcare fraud, waste, and abuse that are under increasing government scrutiny.”
“This acquisition allows us to provide more customers with the most experienced, highly certified neuromonitoring professionals in the marketplace,” said Samuel Weinstein, MD, MBA, SpecialtyCare’s President and Chief Medical Officer. “Sentient’s additional case volume increases the clinical data collected in the SpecialtyCare Operative Procedural Registry, SCOPE™, which is already the largest national multi-institutional database of its kind. The Sentient team and its customers will now benefit from SpecialtyCare’s online dashboards, which provide access to data for continuous improvement in clinical competency, operational expense, and efficiency.”
More than 1,200 hospitals and 13,500 physicians trust SpecialtyCare to help them achieve exceptional care outcomes, regulatory compliance, and financial results. With nearly 1,500 clinicians supporting over 375,000 procedures annually, we maintain the SpecialtyCare Operative Procedural Registry (SCOPE™), the largest procedural database of its kind, which we use to identify standards, determine benchmarks, disseminate best practices, and foster innovations that improve patient outcomes, increase efficiencies, and minimize costs. We are accredited and certified by The Joint Commission. By developing expertise beyond industry requirements, our customers can be certain they have the best partner for clinical excellence in perfusion, intraoperative neuromonitoring, autotransfusion, sterile processing management, surgical assist, and minimally invasive surgical support.
Senior Vice President, Marketing